<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background: Diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> is the leading cause of <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Myocardial dysfunction may occur in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM) in the absence of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> or left ventricular (LV) <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Although tissue Doppler imaging (<z:chebi fb="0" ids="53555">TDI</z:chebi>) is a highly effective means of quantifying myocardial diastolic function, its differences in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> patients with <z:mp ids='MP_0002055'>diabetes</z:mp> and without <z:mp ids='MP_0002055'>diabetes</z:mp> remain unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Methods and Results: A total of 101 ESRD patients on maintenance hemodialysis with <z:mpath ids='MPATH_458'>normal</z:mpath> LV systolic function were studied: 37 with type 2 DM and 64 without DM </plain></SENT>
<SENT sid="4" pm="."><plain>Conventional echocardiography and <z:chebi fb="0" ids="53555">TDI</z:chebi> were performed to evaluate LV systolic and diastolic functions </plain></SENT>
<SENT sid="5" pm="."><plain>The conventional LV systolic and diastolic echocardiographic parameters did not differ according to presence of DM, except for the left atrial size and volume index (P&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> patients with DM, however, had significantly decreased mitral annular early diastolic peak velocity (e') and ratio of early to late diastolic mitral annular velocity (e'/a'; both P&lt;0.02) </plain></SENT>
<SENT sid="7" pm="."><plain>Additionally, the group with DM had markedly higher estimated LV end-diastolic filling pressure (E/e'; P=0.011) </plain></SENT>
<SENT sid="8" pm="."><plain>Conclusions: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> patients with DM had advanced LV diastolic dysfunction on <z:chebi fb="0" ids="53555">TDI</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> patients with DM, diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> associated with advanced LV diastolic dysfunction is observed.  (Circ J 2012; 76: 2380-2385) </plain></SENT>
</text></document>